| 病態生理学研究室 | |
| 研究室ページ | English | |
|
|
|
 |
論文リスト |
1. |
Extracellular Vesicles Derived from 3T3-L1 Adipocytes Enhance Procoagulant Activity; Nakatani, N., Naito, Y., Ishibashi, K., Ohkura, N. and Atsumi, G.; Biol. Pharm. Bull., 45, 178-183 (2022) |
2. |
Exposure to stearate activates the IRE1α/XBP-1 pathway in 3T3-L1 adipocytes; Takeda, Y., Ishibashi, K., Kuroda, Y. and Atsumi, G.; Biol. Pharm. Bull., 44, 1752-1758 (2021) |
3. |
Extracellular Elaidate, a Trans Fatty Acid, Tends to be Incorporated into Triglycerides and Incorporated Elaidate is Released by Lipolysis; Ishibashi, K. and Atsumi, G.; BPB Reports, 4, 120-123 (2021) |
4. |
帝京大学におけるオンライン授業による統合型演習の実践 ー薬学性300人を対象とした問題基盤型学習による症例検討ー; 岸本成史, 渡邊真知子, 安藤崇仁, 厚味厳一, 板垣文雄, 大藏直樹, 岩澤晴代, 長谷川仁美, 長田洋一, 小佐野博史, 奥直人; 薬学教育, 5, doi: 10.24489/jjphe.2020-071 (2021) |
5. |
Screening natural compounds derived from crude drugs that suppress plasminogen activator inhibitor 1 (PAI-1) production by vascular endothelial cells: Inhibitors of PAI-1 production as antithrombotic agents; Ohkura, N. and Atsumi, G.; Journal of Japan Mibyou Association. in press, (2021) |
6. |
Elaidate, a trans fatty acid, suppresses insulin signaling for glucose uptake in a manner distinct from that of stearate; Ishibashi, K.,Takeda, Y., Nakata, L., Hakuno, F., Takahashi, SI., Atsumi, G.; Biochimie. 117, 98-107 (2020) |
7. |
データベースを利用して和文で書かれた｢精油を用いた臨床研究論文｣を検索する方法の検討 ; 石橋賢一、笠嶋奎亮、厚味厳一; 日本アロマセラピー学会学会誌, 19, 30-36 (2020) |
8. |
精油を用いた臨床研究論文を効率的に検索する方法の検討（第2報） ; 石橋賢一、二瓶和樹、厚味厳一; 日本アロマセラピー学会学会誌, 18, 7-13 (2019) |
9. |
Elevated expression of vascular adhesion molecule-1, plasminogen activator inhibitor-1, cyclooxygenase-2, and thrombomodulin in human umbilical vein endothelial cells from hospitalized gestational diabetes mellitus patients; Takata Y., Nomura K., Ishibashi K., Kido K., Sasamori Y., Hiraike H., Ayabe T., Atsumi G.; Biol. Pharm. Bull. 42(5), 807-813 (2019) |
10. |
Ashitaba (Angelica keiskei) Exerts Possible Beneficial Effects on Metabolic Syndrome; Ohkura N, Atsumi G, Uehara S, Ohta M, Taniguchi M; OBM Integrative and Complementary Medicine. 4(1), doi:10.21926/obm.icm.1901005 (2019) |
11. |
Elevated expression of vascular adhesion molecule-1, plasminogen activator inhibitor-1, cyclooxygenase-2, and thrombomodulin in human umbilical vein endothelial cells from hospitalized gestational diabetes mellitus patients; Takata Y., Nomura K., Ishibashi K., Kido K., Sasamori Y., Hiraike H., Ayabe T., Atsumi G.; Biol. Pharm. Bull. 42(5), 807-813 (2019) |
12. |
精油を用いた臨床研究論文を効率的に検索する方法の検討 ; 二瓶和樹、石橋賢一、厚味厳一; 日本アロマセラピー学会学会誌, 17, 47-56 (2018) |
13. |
Effects of fermented rice vinegar Kurozu and its sediment on inflammation-induced plasminogen activator inhibitor 1 (PAI-1) increase; Ohkura, N., Kihara-Negishi, F., Fujii, A., Kanouchi, H., Oishi, K., Atsumi, G., Nagano, M.; Food and Nutrition Sciences. 9(3), 235-245 (2018) |
14. |
An in vitro screening study of food functions among vegetable cultivars consumed in Japan; Ohkura, N., Fujita, R., Kanai, R., Ishibashi, K., Ueda, H., Atsumi, G.; Am J Res Med Sci. 3(1), 1-6 (2018) |
15. |
Possible antithrombotic effects of Angelica keiskei (Ashitaba); Ohkura, N., Atsumi, G., Ohnishi, K., Baba, K., Taniguchi, M.; Govi-Verlag Pharmazeutischer Verlag GmbH Pharmazie. 73(6), 315-317 (2018) |
16. |
Activation of PPARγ at an early stage of differentiation enhances adipocyte differentiation of MEFs derived from Type II diabetic TSOD mice and alters lipid droplet morphology. ; Ishibashi, K., Takeda, Y., Nakatani, E., Sugawara, K., Imai, R., Sekiguchi, M., Takahama, R., Ohkura, N., Atsumi, G.; Biol Pharm Bull. 40(6), 852-859 (2017) |
17. |
Positions of Hydroxyl Groups in Chrysin are Critical for Inhibiting Plasminogen Activator Inhibitor-1 Release from Human Umbilical Vein Endothelial Cells ;Ohkura, N., Ando, K., Takata, Y., Kanai, S., Ishibashi, K., Taniguchi, M.,Tatefuji, T., Atsumi, G.;Natural Product Communications. 12(4), 499-502 (2017) |
18. |
Anti-platelet effects of chalcones from Angelica keiskei Koidzumi (Ashitaba) in vivo; Ohkura, N.; Ohnishi, K.; Taniguchi, M.; Nakayama, A.; Usuba, Y.; Fujita, M.; Fujii, A.; Ishibashi, K.; Baba, K.; Atsumi, G.;Die Pharmazie. 71(11), 651-654 (2016) |
19. |
Effects of a diet containing Brazilian propolis on lipopolysaccharide-induced increases in plasma plasminogen activator inhibitor-1 levels in mice.; Ohkura, N., Oishi, K., Kihara-Negishi, F., Atsumi, G., Tatefuji, T.;J Intercult Ethnopharmacol. 5(4), 439-443 (2016) |
20. |
Differentiation with elaidate tends to impair insulin-dependent glucose uptake and GLUT4 translocation in 3T3-L1 adipocytes; Ishibashi, K., Nehashi, K., Toshiyuki, O., Ohukura, N., Atsumi, G.; Int. J. Food Sci. Nutr., 67, 99-110 (2016) |
21. |
Inhibition of plasminogen activator inhibitor-1 release from human endothelial cells by Angelica keiskei Koidzumi (Ashitaba) chalcones is structure-dependent; Ohkura, N., Oiwa, H., Ohnishi, K., Taniguchi, M., Baba, K., Atsumi, G.; J. Intercult. Ethnopharmacol., 4(4), 355-357 (2015) |
22. |
Blood coagulation and metabolic profiles in middle-aged male and female ob/ob mice; Ohkura, N., Oishi, K. and Atsumi, GI.; Blood Coagul. Fibrinolysis, [Epub ahead of print] (2015) |
23. |
Screening for hemostatic activities of popular Chinese medicinal herbs in vitro; Ohkura, N., Yokouchi, H., Mimura, M., Nakamura, R. and Atsumi, G.; J. Intercult. Ethnopharmacol., 4(1), 19-23 (2015) |
24. |
妊婦に対して大学が出来ること 〜基礎研究と調査研究を通した挑戦〜; 厚味厳一, 高田裕子; Japanese Journal of Pharmaceutical and Diabetes, 3(2), 121-123 (2014) |
25. |
Lipopolysaccharide-induced plasma PAI-1 increase does not correlate with PAI-1 synthesised de novo in the liver; Ohkura, N., Oishi, K., Nakakuki, Y., Miura, M. and Atsumi, G.; Thromb. Res., 132(3), 398-399 (2013) |
26. |
Acidic sialidase activity is aberrant in obese and diabetic mice; Natori, Y., Ohkura, N., Nasui, M., Atsumi, G. and Kihara-Negishi, F.; Biol. Pharm. Bull., 36(6), 1027-1031 (2013) |
27. |
Associations between plsama PAI-1 concentrations and its expressions in various organs in obese mice model; Ohkura, N., Shirakura, M., Nakatani, E., Oishi K., Atsumi, G.; Thrombosis Res. 130(6), e301-e304 2012) |
28. |
Pollen Typhae is a rapid hemostyptic; Ohkura, N., Tauchi, C., Nakayama, A., Atsumi, G.; Blood Coagul Fibrinolysis. 23(3),254-255 (2012) |
29. |
Propolis and its constituent chrysin inhibit plasminogen activator inhibitor 1 production induced by tumour necrosis factor-α and lipopolysaccharide; Ohkura,N., Takata, Y., Ando, K., Kanai, S., Watanabe, E., Nohira,T., Atsumi, G.;J Apicul. Res. 51 (2),179-184 (2012) |
30. |
Xanthoangelols isolated from Angelica keiskei inhibit inflammatory-induced plasminogen activator inhibitor 1 (PAI-1) production; Ohkura, N., Nakakuki, Y., Taniguchi, M., Kanai, S., Nakayama, A., Ohnishi, K., Sakata, T., Nohira, T., Matsuda, J., Baba, K., Atsumi, G.; Biofactors.37(6), 455-461 (2011) |
31. |
Experimental study on the hemostatc activity of Pollen Typhae: a traditional folk medicine used by external and oral application; Ohkura, N., Tamura, K., Tanaka, A., Matsuda, J., Atsumi, G;. Blood Coagul Fibrinolysis. 22(8), 631-663 (2011) |
32. |
Sole existence of antithrombin antibody in patients with systemic lupus erythematosus showing tendency of its antigenic determinants directing against exosite II (antithrombin/heparin binding site) of thrombin. Matsuda J, Matsuyama A, Atsumi G, Ohkura N.; Blood Coagul Fibrinolysis. 19(1), 66-69 (2008) |
33. |
Circadian variations in coagulation and fibrinolytic factors among four different strains of mice; Ohkura, N., Oishi, K., Sakata, T., Kadota, K., Kasamatsu, M., Fukushima, N., Kurata, A., Tamai, Y., Shirai, H., Atsumi, G., Ishida, N., Matsuda, J., Horie, S.; Chronobiol Int.;24(4), 651-669.(2007) |
34. |
Comparative study of circadian variation in numbers of peripheral blood cells among mouse strains: unique feature of C3H/HeN mice; Ohkura, N., Oishi, K., Sekine, Y., Atsumi, G., Ishida, N., Matsuda, J., Horie, S.; Biol Pharm Bull. 30(6), 1177-1180 (2007) |
35. |
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2; Furuhashi M, Tuncman G, G?rg?n CZ, Makowski L, Atsumi G, Vaillancourt E, Kono K, Babaev VR, Fazio S, Linton MF, Sulsky R, Robl JA, Parker RA, Hotamisligil GS., Nature 447(7147), 959-65 (2007) |
|
36.
|
CLOCK is involved in obesity-induced disordered fibrinolysis in ob/ob mice by regulating PAI-1 gene expression; Oishi, K., Ohkura, N., Wakabayashi, M., Shirai, H., Sato, K., Matsuda, J., Atsumi, G., Ishida, N.; J Thromb Haemost. (8), 1774-1780 (2006) |
|
37.
|
Disrupted fat absorption attenuates obesity induced by a high-fat diet in Clock mutant mice.Oishi, K., Atsumi, G., Sugiyama, S., Kodomari, I., Kasamatsu, M., Machida, K., Ishida, N.;FEBS Lett. 580(1), 127-30 (2006) |
|
38.
|
Genome-wide expression analysis of mouse liver reveals CLOCK-regulated circadian output genes; Oishi, K., Miyazaki, K., Kadota, K., Kikuno, R., Nagase, T., Atsumi, G., Ohkura, N., Azama, T., Mesaki, M., Yukimasa, S., Kobayashi, H., Iitaka, C., Umehara, T., Horikoshi, M., Kudo, T., Shimizu, Y., Yano, M., Monden, M., Machida, K., Matsuda, J., Horie, S., Todo, T., Ishida, N. J Biol Chem. 278(42), 41519-41517 (2003) |
|
著書リスト・その他 |
|
1.
|
Effect of Trans Fatty Acid on Insulin Responsiveness and Fatty Acid Composition of Lipid Species of 3T3-L1 Adipocytes.; Ishibashi, K., Takeda, Y., Atsumi, G.;IntechOpen, Adipose Tissue: section 12, ISBN:978-1-78923-229-5 (2018) |
|
|
|